MIR623

gene
On this page

Also known as hsa-mir-623

Summary

MIR623 (microRNA 623, HGNC:32879) is a microRNA gene on chromosome 13q32.3.

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.

Source: NCBI Gene 693208 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:32879
Approved symbolMIR623
NamemicroRNA 623
Location13q32.3
Locus typeRNA, micro
StatusApproved
Aliaseshsa-mir-623
Ensembl geneENSG00000207719
Ensembl biotypemiRNA
Entrez693208
RNAcentralURS000075BF27 — miRNA, 98 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 miRNA

ENST00000384986

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000384986 — 1 exons

ExonStartEnd
ENSE000014999939935613199356228

Expression profiles

Bgee: expression breadth broad, 99 present calls, max score 91.81.

Top tissues by expression

99 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
olfactory segment of nasal mucosaUBERON:000538691.81gold quality
bone marrowUBERON:000237183.52gold quality
adrenal tissueUBERON:001830383.30gold quality
bloodUBERON:000017882.33gold quality
monocyteCL:000057680.73gold quality
gastrocnemiusUBERON:000138876.34gold quality
skin of abdomenUBERON:000141676.21gold quality
calcaneal tendonUBERON:000370175.63gold quality
corpus callosumUBERON:000233675.43gold quality
liverUBERON:000210775.27gold quality
zone of skinUBERON:000001474.67gold quality
stomachUBERON:000094574.60gold quality
placentaUBERON:000198774.58gold quality
skin of legUBERON:000151173.68gold quality
adult mammalian kidneyUBERON:000008273.51gold quality
lymph nodeUBERON:000002973.46gold quality
islet of LangerhansUBERON:000000673.38gold quality
urinary bladderUBERON:000125573.20gold quality
left coronary arteryUBERON:000162673.01gold quality
substantia nigraUBERON:000203872.28gold quality
pancreasUBERON:000126472.27gold quality
kidneyUBERON:000211372.23gold quality
body of stomachUBERON:000116172.00gold quality
heartUBERON:000094871.84gold quality
fundus of stomachUBERON:000116071.57gold quality
subcutaneous adipose tissueUBERON:000219071.49gold quality
lower esophagus muscularis layerUBERON:003583371.47gold quality
body of pancreasUBERON:000115071.44gold quality
lower esophagusUBERON:001347371.44gold quality
esophagusUBERON:000104371.11gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.60

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 7)

  • our results suggest that miR-623 might function as a tumor suppressor in GC and could be a promising therapeutic target for patients with GC, especially those with chemotherapeutic resistance. (PMID:29495973)
  • Study demonstrated that hsamiR623 binds to a specific sequence located within the 3’UTR of MMP1 and suppresses MMP1 expression. In addition, hsamiR623 suppressed the IL8induced expression of MMP1 and several EMT functional proteins, consequently inhibiting pancreatic cancer metastasis. (PMID:31115512)
  • Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5. (PMID:31190447)
  • miR-623 suppresses cell proliferation, migration and invasion through direct inhibition of XRCC5 in breast cancer. (PMID:32501811)
  • HIF-1alpha-Mediated miR-623 Regulates Apoptosis and Inflammatory Responses of Nucleus Pulposus Induced by Oxidative Stress via Targeting TXNIP. (PMID:34394829)
  • miR-515-3p, miR-623, miR-1272 and Notch3 protein as new biomarkers of Hepatocellular carcinoma. (PMID:34954928)
  • MiR-623 links lncRNA RP11-89 and cyclin D1 to regulate the proliferation of glioblastoma cells. (PMID:36066507)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.